Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93. (Q35140541)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93. |
scientific article |
Statements
1 reference
Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93. (English)
1 reference
Scott Wadler
1 reference
Donna E Levy
1 reference
Sarah T Lincoln
1 reference
Gamini S Soori
1 reference
Julian C Schink
1 reference
Gary Goldberg
1 reference
1 reference
Identifiers
1 reference